Literature DB >> 28706914

Pleurectomy and decortication.

Tedi Vlahu1, Wicki T Vigneswaran1.   

Abstract

Pleurectomy and decortication (P/D) improve survival and quality of life in selected patients with malignant pleural mesothelioma. The operative procedure was not standardized until recently. The goal of the operation is to perform a macroscopic complete resection of the tumor. This often involves resection of the parietal and visceral pleura and invariably a partial or complete resection and prosthetic reconstruction of ipsilateral hemidiaphragm. We describe our operative planning and technique as well as outcomes of P/D reported in current literature.

Entities:  

Keywords:  Malignant pleural mesothelioma; macroscopic complete resection; pleurectomy and decortication (P/D)

Year:  2017        PMID: 28706914      PMCID: PMC5497109          DOI: 10.21037/atm.2017.04.03

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  25 in total

1.  Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.

Authors:  Ottavio Rena; Caterina Casadio
Journal:  Lung Cancer       Date:  2012-01-11       Impact factor: 5.705

2.  Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.

Authors:  Loïc Lang-Lazdunski; Andrea Bille; Rohit Lal; Paul Cane; Emma McLean; David Landau; Jeremy Steele; James Spicer
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

3.  May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?

Authors:  Tommaso Claudio Mineo; Vincenzo Ambrogi; Maria Elena Cufari; Eugenio Pompeo
Journal:  Eur J Cardiothorac Surg       Date:  2010-03-24       Impact factor: 4.191

4.  Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma.

Authors:  Tristan D Yan; Michael Boyer; Mo Mo Tin; Junyang Sim; Catherine Kennedy; Jocelyn McLean; Paul G Bannon; Brian C McCaughan
Journal:  Ann Thorac Surg       Date:  2009-05       Impact factor: 4.330

5.  Standardizing surgical treatment in malignant pleural mesothelioma.

Authors:  David Rice
Journal:  Ann Cardiothorac Surg       Date:  2012-11

6.  Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.

Authors:  Apostolos Nakas; Eric von Meyenfeldt; Kelvin Lau; Salli Muller; David Waller
Journal:  Eur J Cardiothorac Surg       Date:  2011-12-16       Impact factor: 4.191

7.  Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma.

Authors:  H I Pass; B K Temeck; K Kranda; G Thomas; A Russo; P Smith; W Friauf; S M Steinberg
Journal:  Ann Surg Oncol       Date:  1997-12       Impact factor: 5.344

8.  Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.

Authors:  Piero Borasio; Alfredo Berruti; Andrea Billé; Paolo Lausi; Matteo Giaj Levra; Roberto Giardino; Francesco Ardissone
Journal:  Eur J Cardiothorac Surg       Date:  2008-02       Impact factor: 4.191

9.  Three decades of experience in the surgical multi-modality management of pleural mesothelioma.

Authors:  Heyman Luckraz; Mesbah Rahman; Nishith Patel; Adam Szafranek; Allen R Gibbs; Eric G Butchart
Journal:  Eur J Cardiothorac Surg       Date:  2009-08-29       Impact factor: 4.191

10.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

View more
  2 in total

1.  Non-incisional pleurectomy-decortication for malignant pleural mesothelioma.

Authors:  Fumihiro Tanaka; Naoko Imanishi; Masaru Takenaka; Akihiro Taira
Journal:  Surg Today       Date:  2018-02-28       Impact factor: 2.549

Review 2.  Landmark Trials in the Surgical Management of Mesothelioma.

Authors:  Taylor Kantor; Elliot Wakeam
Journal:  Ann Surg Oncol       Date:  2021-01-31       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.